Case number 2017-1120
Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 1, 2018 | 62 | Mandate issued to the United States District Court for the District of Massachusetts. Service as of this date by the Clerk of Court. [502008] [SJ] [Entered: 03/01/2018 11:58 AM] (1) |
| Jan 23, 2018 | 61 | ORDER filed dismissing appeal as moot. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [491727] [SJ] [Entered: 01/23/2018 09:46 AM] (2) |
| Oct 3, 2017 | 60 | Submitted after ORAL ARGUMENT by Gregory Diskant for New York University and Janssen Biotech, Inc. and James F. Hurst for Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. Panel: Judge: Prost , Judge: Reyna , Judge: Wallach. [465119] [JAB] [Entered: 10/03/2017 12:46 PM] (0) |
| Sep 18, 2017 | 59 | Response to oral argument order from the Appellants Janssen Biotech, Inc. and New York University. designating Gregory L. Diskant as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [461827] [Eugene Gelernter] [Entered: 09/18/2017 03:53 PM] (0) |
| Sep 18, 2017 | 58 | Notice to counsel for Appellants Janssen Biotech, Inc. and New York University: The record of this case indicates that the Response to Oral Argument Order has not been filed. The response was due on or before 9/15/2017. Counsel should promptly docket the Response to Oral Argument Order event and designate which attorney will present argument for the parties. Service as of this date by Clerk of Court. [461584] [JAB] [Entered: 09/18/2017 08:28 AM] (0) |
| Sep 15, 2017 | 57 | Response to oral argument order from the Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. designating James F. Hurst as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [461511] [William Burgess] [Entered: 09/15/2017 04:18 PM] (0) |
| Aug 21, 2017 | 56 | NOTICE OF CALENDARING. Panel: 1710A. Case scheduled Oct 03, 2017 10:00 a.m. at the U.S. Court of International Trade (1 Federal Plaza, New York, NY 10278), Ceremonial Courtroom. Response to oral argument order due: 09/15/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [455482] [JAB] [Entered: 08/21/2017 03:37 PM] (0) |
| Jun 14, 2017 | 55 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 06/21/2017. [439142] [CAB] [Entered: 06/14/2017 11:24 AM] (0) |
| Jun 13, 2017 | 54 | Notice from Appellant Janssen Biotech, Inc. regarding conflicts with oral argument (8/07-11/2017; 9/05-08/2017; and 10/04-06/2017 ). Service: 06/13/2017 by email. [438832] [Gregory Diskant] [Entered: 06/13/2017 01:41 PM] (1) |
| Jun 12, 2017 | 53 | Notice from Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. regarding conflicts with oral argument (August 7-11, September 5). Service: 06/12/2017 by email. [438567] [William Burgess] [Entered: 06/12/2017 10:16 PM] (2) |
| May 4, 2017 | 52 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Janssen Biotech, Inc., New York University and Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 05/04/2017 by email. [429108] [William Burgess] [Entered: 05/04/2017 11:33 AM] (2) |
| May 2, 2017 | 51 | 6 paper copies of the Joint Appendix (Vol. I-II) [50] received from Appellants Janssen Biotech, Inc. and New York University. [428575] [KW] [Entered: 05/02/2017 02:56 PM] (0) |
| Apr 27, 2017 | 50 | JOINT APPENDIX, VOLS. I - II FILED for Janssen Biotech, Inc. and New York University [49]. Number of Pages: 852. Service: 04/27/2017 by email. The paper copies of the brief should be received by the court on or before 05/05/2017. [427811] [CAB] [Entered: 04/28/2017 12:16 PM] (852) |
| Apr 27, 2017 | 49 | TENDERED from Appellants Janssen Biotech, Inc., New York University and Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Title: JOINT APPENDIX. Service: 04/27/2017 by email. [427609] [Gregory Diskant] [Entered: 04/27/2017 03:20 PM] (852) |
| Apr 25, 2017 | 48 | 6 paper copies of the Reply Brief [47] received from Appellants Janssen Biotech, Inc. and New York University. [426978] [KW] [Entered: 04/25/2017 02:53 PM] (0) |
| Apr 20, 2017 | 47 | REPLY BRIEF FILED for Appellants Janssen Biotech, Inc. and New York University [46]. Number of Pages: 30. Service: 04/20/2017 by email. The paper copies of the brief should be received by the court on or before 04/28/2017. Appendix is due 04/27/2017. [426100] [CAB] [Entered: 04/21/2017 10:57 AM] (39) |
| Apr 20, 2017 | 46 | TENDERED from Appellants Janssen Biotech, Inc. and New York University. Title: REPLY BRIEF. Service: 04/20/2017 by email. [425875] [Gregory Diskant] [Entered: 04/20/2017 02:28 PM] (39) |
| Mar 21, 2017 | 45 | ORDER filed. The motion [42] is granted. The appellants' reply brief is due April 20, 2017. Service: 03/21/2017 by clerk. [417566] [LMS] [Entered: 03/21/2017 03:09 PM] (2) |
| Mar 16, 2017 | 44 | 6 paper copies of the Response Brief [43] received from Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. [416264] [KW] [Entered: 03/16/2017 02:37 PM] (0) |
| Mar 10, 2017 | 42 | MOTION of Appellants Janssen Biotech, Inc. and New York University to extend the time to 04/20/2017 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/10/2017 by email. [414430] [Eugene Gelernter] [Entered: 03/10/2017 01:45 PM] (14) |
| Mar 7, 2017 | 43 | BRIEF FILED for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. [41]. Number of Pages: 73. Service: 03/07/2017 by email. The paper copies of the brief should be received by the court on or before 03/21/2017. Appellants Janssen Biotech, Inc. and New York University's reply brief is due 03/21/2017. [415369] [CAB] [Entered: 03/14/2017 02:53 PM] (85) |
| Mar 7, 2017 | 41 | TENDERED from Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Title: RESPONSE BRIEF. Service: 03/07/2017 by email. [413201] [William Burgess] [Entered: 03/07/2017 06:42 PM] (85) |
| Mar 7, 2017 | 40 | Entry of appearance for Elizabeth A. Cutri as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 03/07/2017 by email. [413013] [Elizabeth Cutri] [Entered: 03/07/2017 01:27 PM] (2) |
| Feb 27, 2017 | 39 | **TEXT ONLY** ORDER granting motion to withdraw attorney [38] Peter B. Silverman filed by Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [410968] [CAB] [Entered: 02/27/2017 04:17 PM] (0) |
| Feb 24, 2017 | 38 | MOTION of Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. to withdraw counsel Peter B. Silverman. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/24/2017 by email. [410312] [William Burgess] [Entered: 02/24/2017 09:22 AM] (4) |
| Feb 2, 2017 | 37 | 6 paper copies of the Opening Brief [36] received from Appellants Janssen Biotech, Inc. and New York University. [404218] [KW] [Entered: 02/02/2017 02:10 PM] (0) |
| Jan 26, 2017 | 36 | BRIEF FILED for Appellants Janssen Biotech, Inc. and New York University [35]. Number of Pages: 62. Service: 01/26/2017 by email. The paper copies of the brief should be received by the court on or before 02/07/2017. Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc., and Hospira Inc.'s brief is due 03/07/2017. [403367] [CAB] [Entered: 01/31/2017 12:06 PM] (264) |
| Jan 26, 2017 | 35 | TENDERED from Appellants Janssen Biotech, Inc. and New York University. Title: OPENING BRIEF. Service: 01/26/2017 by email. [402445] [Gregory Diskant] [Entered: 01/26/2017 04:46 PM] (264) |
| Dec 16, 2016 | 34 | Note to file: 17-1257 (COMPANION started 12/16/2016) with 17-1120. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [391982] [17-1120, 17-1257] [CAB] [Entered: 12/16/2016 04:47 PM] (0) |
| Dec 13, 2016 | 33 | ORDER filed. The motion [24] is granted. The appellants' opening brief is due January 26, 2017. Service: 12/13/2016 by clerk. [390717] [LMS] [Entered: 12/13/2016 04:15 PM] (2) |
| Dec 8, 2016 | 32 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file appellant's principal brief, Docket No. [24], and reply Docket No. [31], ERROR: The caption on both documents do not follow official caption provided by the clerk. CORRECTION: In the future, documents submitted must follow official caption provided by the clerk. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [389502] [CAB] [Entered: 12/08/2016 01:35 PM] (0) |
| Dec 7, 2016 | 31 | REPLY of Appellants Janssen Biotech, Inc. and New York University to response filed by Appellees in 17-1120 , Doc. No [29]. Service: 12/07/2016 by email. [389059] [Eugene Gelernter] [Entered: 12/07/2016 02:17 PM] (9) |
| Dec 7, 2016 | 30 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [388840] [CAB] [Entered: 12/07/2016 09:11 AM] (0) |
| Dec 6, 2016 | 29 | RESPONSE of Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. to the motion to extend time to file appellant/petitioner principal brief [24] filed by Appellants New York University and Janssen Biotech, Inc. in 17-1120. Service: 12/06/2016 by email. [388559] [William Burgess] [Entered: 12/06/2016 11:54 AM] (20) |
| Dec 6, 2016 | 28 | Amended Certificate of Interest for the Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 12/06/2016 by email. [388557] [William Burgess] [Entered: 12/06/2016 11:50 AM] (3) |
| Dec 6, 2016 | 27 | Entry of appearance for Calvin Alexander Shank as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 12/06/2016 by email. [388547] [Calvin Shank] [Entered: 12/06/2016 11:37 AM] (2) |
| Dec 5, 2016 | 26 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Doctor Jason Weil for New York University and Janssen Biotech, Inc.. The e-mail address, (tdeantoneo@akingump.com), associated with your CM/ECF account has generated a delivery failure notice. Counsel should promptly report a change in contact information with the Pacer Service Center (see Fed. Cir. R. 47.3(c)(1). [388301] [PMM] [Entered: 12/05/2016 03:56 PM] (0) |
| Dec 5, 2016 | 25 | Letter from Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. Opposition to Janssen's Motion for Extension of Time (Dkt. 24). Service: 12/05/2016 by email. [388146] [William Burgess] [Entered: 12/05/2016 12:01 PM] (21) |
| Dec 2, 2016 | 24 | MOTION of Appellants Janssen Biotech, Inc. and New York University to extend the time to 01/26/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: opposed]. Service: 12/02/2016 by email. [388012] [Eugene Gelernter] [Entered: 12/02/2016 05:27 PM] (12) |
| Nov 14, 2016 | 23 | Entry of appearance for Dan H. Hoang as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382853] [Dan Hoang] [Entered: 11/14/2016 05:25 PM] (2) |
| Nov 14, 2016 | 22 | Entry of appearance for Melinda K. Lackey as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382852] [Melinda Lackey] [Entered: 11/14/2016 05:23 PM] (2) |
| Nov 14, 2016 | 21 | Entry of appearance for Samuel S. Park as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382847] [Samuel Park] [Entered: 11/14/2016 05:19 PM] (2) |
| Nov 14, 2016 | 20 | Entry of appearance for Charles B. Klein as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382841] [Charles Klein] [Entered: 11/14/2016 05:16 PM] (2) |
| Nov 14, 2016 | 19 | Docketing Statement for the Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382629] [William Burgess] [Entered: 11/14/2016 02:44 PM] (3) |
| Nov 14, 2016 | 18 | Certificate of Interest for the Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382613] [William Burgess] [Entered: 11/14/2016 02:34 PM] (3) |
| Nov 14, 2016 | 17 | Entry of appearance for William H. Burgess as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382611] [William Burgess] [Entered: 11/14/2016 02:31 PM] (2) |
| Nov 14, 2016 | 16 | Entry of appearance for Peter B. Silverman as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382610] [William Burgess] [Entered: 11/14/2016 02:30 PM] (2) |
| Nov 14, 2016 | 15 | Entry of appearance for John C. O'Quinn as of counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382608] [William Burgess] [Entered: 11/14/2016 02:28 PM] (2) |
| Nov 14, 2016 | 14 | Entry of appearance for James F. Hurst, P.C. as principal counsel for Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc.. Service: 11/14/2016 by email. [382605] [William Burgess] [Entered: 11/14/2016 02:27 PM] (2) |
| Nov 14, 2016 | 13 | Entry of appearance for Irena Royzman as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/14/2016 by email. [382387] [Irena Royzman] [Entered: 11/14/2016 10:45 AM] (1) |
| Nov 14, 2016 | 12 | NOTICE OF DEFICIENCY: The attorney entry of appearance for Irena Royzman Document No. [4] filed by Appellants New York University and Janssen Biotech, Inc. in 17-1120 lists attorney as pricipal in the docket event but selected counsel of record on the entry of appearance form. Attorney Gregory Diskant is also listed as principal on this case, as a reminder per Fed. Cir. Rule 47.3 only one attorney may appear as principal. This discrepancy prevents us from accepting Irena Royzman's filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [382374] [CMP] [Entered: 11/14/2016 10:29 AM] (0) |
| Nov 14, 2016 | 11 | Entry of appearance for Jason Weil as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by email. [382230] [Dianne Elderkin] [Entered: 11/11/2016 03:28 PM] (2) |
| Nov 14, 2016 | 10 | Entry of appearance for Angela Verrecchio as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by email. [382229] [Dianne Elderkin] [Entered: 11/11/2016 03:28 PM] (2) |
| Nov 14, 2016 | 9 | Entry of appearance for Barbara L. Mullin as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by email. [382228] [Dianne Elderkin] [Entered: 11/11/2016 03:27 PM] (2) |
| Nov 14, 2016 | 8 | Entry of appearance for Dianne B. Elderkin as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by email. [382227] [Dianne Elderkin] [Entered: 11/11/2016 03:26 PM] (2) |
| Nov 14, 2016 | 7 | Certificate of Interest for the Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382215] [Gregory Diskant] [Entered: 11/11/2016 01:10 PM] (2) |
| Nov 14, 2016 | 6 | Docketing Statement for the Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382214] [Gregory Diskant] [Entered: 11/11/2016 01:07 PM] (3) |
| Nov 14, 2016 | 5 | Entry of appearance for Aron Fischer as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382213] [Aron Fischer] [Entered: 11/11/2016 01:04 PM] (1) |
| Nov 14, 2016 | 4 | Entry of appearance for Irena Royzman as principal counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382212] [Irena Royzman] [Entered: 11/11/2016 01:01 PM] (0) |
| Nov 14, 2016 | 3 | Entry of appearance for Eugene M. Gelernter as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382211] [Eugene Gelernter] [Entered: 11/11/2016 12:59 PM] (1) |
| Nov 14, 2016 | 2 | Entry of appearance for Gregory L. Diskant as principal counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382210] [Gregory Diskant] [Entered: 11/11/2016 12:55 PM] (1) |
| Oct 28, 2016 | 1 | Appeal docketed. Received: 10/25/2016. [378336]Entry of Appearance due 11/14/2016. Certificate of Interest is due on 11/14/2016. Docketing Statement due 11/14/2016. Appellant's brief is due 12/27/2016. [CAB] [Entered: 10/28/2016 12:23 PM] (105) |
